mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.3 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.04 |